Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2012-08-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
If the involvement of milk in these pathologies is suggested by some early studies (35% for colics, 68% in constipation, 42% in gastroesophageal reflux), it is unclear in the current state of knowledge if these gastrointestinal symptoms are actually due to an "allergy" to milk. Moreover, there is no validated diagnostic test for non-IgE-mediated gut allergy. However, various tests have proven their effectiveness in the investigation of non IgE-mediated allergy (eg. LAT, patch tests) and will be used in this study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
GI Symptoms in Infants Fed Goat Milk-based Infant Formula
NCT06755424
Effect Of a Goat Milk-Based Infant Formula On Gastrointestinal And Other Symptoms And Health-Related Quality Of Life.
NCT06108401
Treatment of Gastroesophageal Reflux Disease in Infants
NCT06255886
Efficacy of a New Thickened Extensively Hydrolyzed Formula
NCT01985607
GI Symptoms in Infants Fed GMF or CMF
NCT06395571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infant formula milk
Infant formula milk adapted to age of infant
Placebo
Infant formula milk
Formula milk free of milk proteins
Milk-free formula milk adapted to age of infant
Formula milk free of cow's milk protein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Formula milk free of cow's milk protein
Placebo
Infant formula milk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* exclusive breastfeeding
* Other cause for symptoms
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Geneva
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Philippe Eigenmann
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe A Eigenmann, MD
Role: STUDY_DIRECTOR
Hôpitaux Unversitaire de Genève
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève
Geneva, Canton of Geneva, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-202 (MATPED 11-047)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.